Fulminant hepatitis due to human adenovirus

Infection

Volumn 42, Issue 1, 2014, Pages 105-111

  Ronan, B A ^a   Agrwal, N ^a   Carey, E J ^a   De Petris, G ^a   Kusne, S ^a   Seville, M T ^a   Blair, J E ^a   Vikram, H R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute liver failure; Adenovirus; Hepatic failure; Hepatitis; Rituximab

Indexed keywords

ACICLOVIR; ALKALINE PHOSPHATASE; CIDOFOVIR; FLUDARABINE; IMMUNOGLOBULIN; MEROPENEM; RITUXIMAB; STEROID; VANCOMYCIN; VORICONAZOLE;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD CULTURE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FEVER; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEPATITIS; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS HEPATITIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; KIDNEY GRAFT; LEUKOPENIA; LIVER ABSCESS; LIVER BIOPSY; LIVER GRAFT; LYMPHADENOPATHY; LYMPHOCYTOPENIA; MEDICAL RECORD REVIEW; MORTALITY; MULTIPLE ORGAN FAILURE; PNEUMOCYSTIS PNEUMONIA; SEPSIS; SEROLOGY; SEVERE COMBINED IMMUNODEFICIENCY; TACHYCARDIA; URINARY TRACT INFECTION; VIRUS ISOLATION;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BIOPSY; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LIVER; VIDARABINE;

EID: 84898546279     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0527-7     Document Type: Article

References (63)

1. Echavarria M. Adenoviruses in immunocompromised hosts. Clin Microbiol Rev. 2008;21:704-15.
2. Ison MG. Adenovirus infections in transplant recipients. Clin Infect Dis. 2006;43:331-9. (Pubitemid 44078906)
3. Matthes-Martin S, Feuchtinger T, Shaw PJ, Engelhard D, Hirsch HH, Cordonnier C, et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4. Transpl Infect Dis. 2011;14:555-63.
4. Carrigan DR. Adenovirus infections in immunocompromised patients. Am J Med. 1997;102:71-4.
5. Abzug MJ, Levin MJ. Neonatal adenovirus infection: four patients and review of the literature. Pediatrics. 1991;87:890-6.
6. Arav-Boger R, Echavarria M, Forman M, Charache P, Persaud D. Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr Infect Dis J. 2000;19:1097-100.
7. Aterman K, Embil J, Easterbrook KB, Haldane EV, Crosby J. Liver necrosis, adenovirus type 2 and thymic dysplasia. Virchows Arch A Pathol. 1973;360:155-71.
8. Benyesh-Melnick M, Rosenberg HS. The isolation of adenovirus type 7 from a fatal case of pneumonia and disseminated disease. J Pediatr. 1964;64:83-7.
9. Bertheau P, Parquet N, Ferchal F, Gluckman E, Brocheriou C. Fulminant adenovirus hepatitis after allogeneic bone marrow transplantation. Bone Marrow Transpl. 1996;17:295-8. (Pubitemid 26057325)
10. Brundler MA, Rodriguez-Baez N, Jaffe R, Weinberg AG, Rogers BB. Adenovirus ascending cholangiohepatitis. Pediatr Dev Pathol. 2003;6:156-9. (Pubitemid 36433501)
11. Cames B, Rahier J, Burtomboy G, de Ville de Goyet J, Reding R, Lamy M, et al. Acute adenovirus hepatitis in liver transplant recipients. J Pediatr. 1992;120:33-7.
12. Carmichael GP Jr, Zahradnik JM, Moyer GH, Porter DD. Adenovirus hepatitis in an immunosuppressed adult patient. Am J Clin Pathol. 1979;71:352-5. (Pubitemid 9188295)
13. Chakrabarti S, Collingham KE, Fegan CD, Milligan DW. Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transpl. 1999;23:1209-11. (Pubitemid 29259681)
14. Chakrabarti S, Mautner V, Osman H, Collingham KE, Fegan CD, Klapper PE, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood. 2002;100:1619-27. (Pubitemid 34925137)
15. Charles AK, Caul EO, Porter HJ, Oakhill A. Fatal adenovirus 32 infection in a bone marrow transplant recipient. J Clin Pathol. 1995;48:779-81.
16. Dombrowski F, Eis-Hubinger AM, Ackermann T, Blumel J, Spengler U, Pfeifer U. Adenovirus-induced liver necrosis in a case of AIDS. Virchows Arch. 1997;431:469-72. (Pubitemid 27519381)
17. Engelmann G, Heim A, Greil J, Schmitt CP, Flechtenmacher C, Daum E, et al. Adenovirus infection and treatment with cidofovir in children after liver transplantation. Pediatr Transpl. 2009;13: 421-8.
18. Faden H, Jockin H, Talty MR, Fazilli R, Barrett H. Fatal disseminated adenovirus infection featuring liver necrosis and prolonged viremia in an immunosuppressed child with malignant histiocytosis. Am J Pediatr Hematol/Oncol. 1985;7:15-20. (Pubitemid 15002506)
19. Fassas AB, Buddharaju LN, Rapoport A, Cottler-Fox M, Drachenberg C, Meisenberg B, et al. Fatal disseminated adenoviral infection associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation. Leuk Lymph. 2001;42:801-4. (Pubitemid 32782788)
20. Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis. 1994;169: 775-81. (Pubitemid 24102109)
21. Gupta A, Philip A, Ranga K, Cappa J, Dougherty J, Lawlor M. An interesting case of adenoviral hepatitis in a cardiac transplant recipient. Transpl Infect Dis. 2013;12:84-6.
22. Hale GA, Heslop HE, Krance RA, Brenner MA, Jayawardene D, Srivastava DK, et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transpl. 1999;23:277-82. (Pubitemid 29078342)
23. Haura EB, Winden MA, Proia AD, Trotter JE. Fulminant hepatic failure due to disseminated adenovirus infection in a patient with chronic lymphocytic leukemia. Cancer Control. 2002;9:248-53. (Pubitemid 34657287)
24. Hogan WJ, Edwards WD, Macon WR, Habermann TM. Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma. Leuk Lymph. 2001;42:1145-50. (Pubitemid 32827539)
25. Hough R, Chetwood A, Sinfield R, Welch J, Vora A. Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2005;27: 67-72. (Pubitemid 40271106)
26. Ivan D, Frazier OH, Abrams J. Fatal disseminated adenoviral infection in an adult heart transplant patient. J Heart Lung Transpl. 2004;23:1209-12. (Pubitemid 39346239)
27. Iyer A, Mathur R, Deepak BV, Sinard J. Fatal adenoviral hepatitis after rituximab therapy. Arch Pathol Lab Med. 2006;130: 1557-60. (Pubitemid 44520727)
28. Johnson PR, Yin JA, Morris DJ, Desai M, Cinkotai KI, McKeogh MM. Fulminant hepatic necrosis caused by adenovirus type 5 following bone marrow transplantation. Bone Marrow Transpl. 1990;5:345-7. (Pubitemid 20184968)
29. Kaur B, Gottardo NG, Keil AD, Hallam LA, Baker DL. A rare case of adenoviral fulminant hepatic necrosis after chemotherapy. Pediatr Hematol Oncol. 2002;19:361-71. (Pubitemid 34633371)
30. Koneru B, Atchison R, Jaffe R, Cassavilla A, Van Thiel DH, Starzl TE. Serological studies of adenoviral hepatitis following pediatric liver transplantation. Transpl Proc. 1990;22: 1547-8.
31. Koneru B, Jaffe R, Esquivel CO, Kunz R, Todo S, Iwatsuki S, et al. Adenoviral infections in pediatric liver transplant recipients. JAMA. 1987;258:489-92. (Pubitemid 17096178)
32. Krilov LR, Rubin LG, Frogel M, Gloster E, Ni K, Kaplan M, et al. Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states. Rev Infect Dis. 1990;12:303-7. (Pubitemid 20118657)
33. Ljungman P, Ehrnst A, Bjorkstrand B, Hellstrom E, Ingelman-Sundberg H, Juliusson G, et al. Lethal disseminated adenovirus type 1 infection in a patient with chronic lymphocytic leukemia. Scand J Infect Dis. 1990;22:601-5. (Pubitemid 20354259)
34. Longerich T, Haferkamp K, Tox U, Schirmacher P, Longerich T, Haferkamp K, et al. Acute liver failure in a renal transplant patient caused by adenoviral hepatitis superimposed on a fibrosing cholestatic hepatitis B. Hum Pathol. 2004;35:894-7. (Pubitemid 38903086)
35. McGrath D, Falagas ME, Freeman R, Rohrer R, Fairchild R, Colbach C, et al. Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance. J Infect Dis. 1998;177:459-62. (Pubitemid 28063775)
36. Michaels MG, Green M, Wald ER, Starzl TE. Adenovirus infection in pediatric liver transplant recipients. J Infect Dis. 1992;165:170-4.
37. Nakazawa H, Ito T, Makishima H, Misawa N, Okiyama W, Uehara T, et al. Adenovirus fulminant hepatic failure: disseminated adenovirus disease after unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia. Intern Med. 2006;45:975-80. (Pubitemid 44420504)
38. Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transpl. 2007;13:74-81. (Pubitemid 46044089)
39. Niemann TH, Trigg ME, Winick N, Penick GD. Disseminated adenoviral infection presenting as acute pancreatitis. Hum Pathol. 1993;24:1145-8. (Pubitemid 23306250)
40. Norris SH, Butler TC, Glass N, Tran R. Fatal hepatic necrosis caused by disseminated type 5 adenovirus infection in a renal transplant recipient. Am J Nephrol. 1989;9:101-5. (Pubitemid 19134823)
41. Ohbu M, Sasaki K, Okudaira M, Iidaka K, Aoyama Y. Adenovirus hepatitis in a patient with severe combined immunodeficiency. Acta Pathologica Japonica. 1987;37:655-64. (Pubitemid 17109286)
42. Perez D, McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Clavien PA. Successful outcome of severe adenovirus hepatitis of the allograft following liver transplantation. Transpl Infect Dis. 2007;9:318-22. (Pubitemid 350059139)
43. Purtilo DT, White R, Filipovich A, Kersey J, Zelkowitz L. Fulminant liver failure induced by adenovirus after bone marrow transplantation. N Engl J Med. 1985;312:1707-8. (Pubitemid 15068583)
44. Rodriguez FH Jr, Liuzza GE, Gohd RH. Disseminated adenovirus serotype 31 infection in an immunocompromised host. Am J Clin Pathol. 1984;82:615-8. (Pubitemid 15203687)
45. Rothenberg M, Cheung R, Ahmed A. Adenovirus-induced acute liver failure. Dig Dis Sci. 2009;54:218-21.
46. Saad RS, Demetris AJ, Lee RG, Kusne S, Randhawa PS. Adenovirus hepatitis in the adult allograft liver. Transplantation. 1997;64:1483-5. (Pubitemid 27513633)
47. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med. 1985;312:529-33. (Pubitemid 15174147)
48. Somervaille TC, Kirk S, Dogan A, Landon GV, Mackinnon S. Fulminant hepatic failure caused by adenovirus infection following bone marrow transplantation for Hodgkin's disease. Bone Marrow Transpl. 1999;24:99-101. (Pubitemid 29346613)
49. Steiner I, Aebi C, Ridolfi Luthy A, Wagner B, Leibundgut K. Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;50:647-9. (Pubitemid 351155846)
50. Terasako K, Oshima K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, et al. Fulminant hepatic failure caused by adenovirus infection mimicking peliosis hepatitis on abdominal computed tomography images after allogeneic hematopoietic stem cell transplantation. Intern Med. 2012;51:405-11.
51. Varki NM, Bhuta S, Drake T, Porter DD. Adenovirus hepatitis in two successive liver transplants in a child. Arch Pathol Lab Med. 1990;114:106-9. (Pubitemid 20103521)
52. Wang WH, Wang HL. Fulminant adenovirus hepatitis following bone marrow transplantation. A case report and brief review of the literature. Arch Pathol Lab Med. 2003;127:e246-8.
53. Wigger HJ, Blanc WA. Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia. N Engl J Med. 1966;275:870-4.
54. Zahradnik JM, Spencer MJ, Porter DD. Adenovirus infection in the immunocompromised patient. Am J Med. 1980;68:725-32. (Pubitemid 10096039)
55. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947-54. (Pubitemid 35440240)
56. Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev. 1992;5:262-74.
57. Kojaoghlanian T, Flomenberg P, Horwitz MS. The impact of adenovirus infection on the immunocompromised host. Rev Med Virol. 2003;13:155-71. (Pubitemid 36566085)
58. Norvell JP, Blei AT, Jovanovic BD, Levitsky J. Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases. Liver Transpl. 2007;13:1428-34. (Pubitemid 47629577)
59. Ljungman P. Prevention and treatment of viral infections in stem cell transplant recipients. Br J Haematol. 2002;118:44-57. (Pubitemid 34779516)
60. Martin-Garrido I, Carmona EM, Specks U, Limper AH. Pneumocystis pneumonia in patients treated with rituximab. Chest. 2013;144:258-65.
61. Safa G, Darrieux L. Cerebral toxoplasmosis after rituximab therapy. JAMA Intern Med. 2013;173:924-6.
62. Aksoy S, Harputluoglu H, Kilickap S, Dede DS, Dizdar O, Altundag K, et al. Rituximab-related viral infections in lymphoma patients. Leuk Lymph. 2007;48:1307-12. (Pubitemid 47079357)
63. Isaacs D. Infectious risks associated with biologics. Adv Exp Med Biol. 2013;764:151-8.